- US well being authorities have authorised Pfizer vaccine for youngsters aged 12 to fifteen years outdated.
- President Joe Biden says it is a promising improvement.
- In response to well being officers, some 1.5 million instances in people aged 11 to 17 years outdated have been reported between March 1, 2020 and April 30, 2021.
WASHINGTON: The US Meals and Drug Administration (FDA) on Monday licensed using the Pfizer-BioNTech COVID-19 vaccine for youngsters aged 12 to fifteen years outdated.
“This is a promising development in our fight against the virus,” mentioned President Joe Biden.
“If you are a parent who wants to protect your child, or a teenager who is interested in getting vaccinated, today’s decision is a step closer to that goal.”
The FDA beforehand granted an emergency use authorization for the Pfizer-BioNTech vaccine to people aged 16 and older.
“Having a vaccine authorized for a younger population is a critical step in continuing to lessen the immense public health burden caused by the COVID-19 pandemic,” mentioned Peter Marks, director of the FDA’s Middle for Biologics Analysis and Analysis.
The FDA mentioned some 1.5 million COVID-19 instances in people aged 11 to 17 years outdated have been reported to the US Facilities for Illness Management and Prevention between March 1, 2020 and April 30, 2021.
The course of the illness is mostly milder in kids however they’ll go it on to older, extra weak adults.
Pfizer and its associate BioNTech mentioned in March that their two-dose vaccine routine was proven to be protected and extremely efficient in a trial of two,260 12 to fifteen 12 months olds.
Biden final week careworn the significance of increasing vaccinations to 12 to fifteen 12 months olds and mentioned the authorities had been “ready to move immediately” as soon as the authorization got here via.
Some 20,000 pharmacies across the nation had been prepared to start to vaccinate adolescents, he mentioned, and doses may even be shipped to pediatricians.
COVID-19 vaccines from Moderna and Johnson & Johnson have additionally obtained emergency use authorizations from the FDA however just for people over the age of 18.
Appearing FDA commissioner Janet Woodcock described Monday’s transfer as a “significant step in the fight against the Covid-19 pandemic.”
“Today’s action allows for a younger population to be protected from Covid-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic,” Woodcock mentioned in a press release.
“Parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our Covid-19 vaccine emergency use authorizations,” she added.